Trials / Completed
CompletedNCT02650609
Treatment of Chronic Subdural Hematoma by Corticosteroids
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 202 (actual)
- Sponsor
- Rennes University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Chronic subdural hematomas are a frequent neurosurgical pathology in the elderly. Gold standard is surgical evacuation of these hematomas. Physiopathology of chronic subdural hematoma involves numerous inflammatory processes which could be inhibited by steroids.
Detailed description
The primary objective is to evaluate the efficacy of corticosteroids treatment in patients with Chronic subdural hematomas without clinical or radiological signs of severity. Secondary objectives are to assess the effect of methylprednisolone on: * quality of life evolution, * morbidity and mortality, * radiological evolution of the lesions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Methylprednisolone | |
| DRUG | Placebo |
Timeline
- Start date
- 2016-06-24
- Primary completion
- 2019-03-20
- Completion
- 2020-03-20
- First posted
- 2016-01-08
- Last updated
- 2020-06-09
Locations
17 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02650609. Inclusion in this directory is not an endorsement.